✦ LIBER ✦

The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis

✍ Scribed by D. W. ORR; R. K. PATEL; N. C. LEA; R. H. WESTBROOK; J. G. O’GRADY; N. D. HEATON; A. PAGLIUCA; G. J. MUFTI; M. A. HENEGHAN

Book ID: 108605921
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 73 KB
Volume: 31
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2010.04299.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of the JAK2 mutation in the diagnos

Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis

✍ Massimo Primignani; Giovanni Barosi; Gaetano Bergamaschi; Umberto Gianelli; Fede 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

High prevalence of the JAK2 V617F mutati

High prevalence of the JAK2 V617F mutation in patients with extrahepatic portal vein thrombosis

✍ Valerio De Stefano; Alessia Fiorini; Elena Rossi; Tommaso Za; Patrizia Chiusolo; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

We read with interest the special article byShneider et al. 1 , which was published in November 2006, but related to a conference held in March 2006. As regards hepatitis B, Shneider et al. state: "Unfortunately at present there are inadequate numbers of patients with sufficiently long follow-up to

Prevalence of the JAK2-V617F mutation in

Prevalence of the JAK2-V617F mutation in Taiwanese patients with chronic myeloproliferative disorders

✍ C.-H. Lieu; H.-S. Wu; Y.-C. Hon; W.-H. Tsai; C.-F. Yang; C.-C. Wang; Y.-C. Lin; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Absence of the JAK2 exon 12 mutations in

Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms

✍ Alessia Fiorini; Patrizia Chiusolo; Elena Rossi; Tommaso Za; Daniela G. De Ritis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 1 views

Incidence of the JAK2 V617F mutation amo

Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders

✍ V. DE STEFANO; A. FIORINI; E. ROSSI; T. ZA; G. FARINA; P. CHIUSOLO; S. SICA; G. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

JAK2V617F prevalence and allele burden i

JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorder

✍ Pardanani, A; Lasho, T L; Schwager, S; Finke, C; Hussein, K; Pruthi, R K; Teffer 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 81 KB